BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 30
• 31

• Biotech Bay

  ProSomnus® Sleep Technologies to Participate at the Oppenheimer Private Company Showcase

  ProSomnus Holdings Inc. today announced that Laing Rikkers, Executive Chairwoman and Co-Founder, is scheduled to participate at the Oppenheimer Private Company Showcase on October 17-18, 2022 at the Four Seasons in Palo Alto, California.

  October 5, 2022

   · 

  1 min read
• Biotech Bay

  Cellecta, Inc. Launches DriverMap™ Adaptive Immune Receptor (AIR) TCR and BCR Kits for Comprehensive Immune Repertoire Profiling

  Cellecta, Inc. announced the launch of the DriverMap™ Adaptive Immune Receptor TCR and BCR kits, a family of multiplex-PCR, NGS-based assays that enable profiling of up to all seven T-cell receptor and B-cell receptor chains from the same sample, in a single tube, without need of specialized equipment.

  October 5, 2022

   · 

  3 min read
• Biotech Bay

  Sestina Bio Uses Inscripta’s Onyx® Platform to Develop Microbial Strain Ready for Scale-up in Less Than 12 Months

  Inscripta, Inc. and Sestina Bio, LLC announced the successful development of a ready-to-scale microbial strain that produces the compound Bakuchiol.

  October 5, 2022

   · 

  3 min read